Henry O Gosebruch - Net Worth and Insider Trading
Henry O Gosebruch Net Worth
The estimated net worth of Henry O Gosebruch is at least $21 Million dollars as of 2024-04-25. Henry O Gosebruch is the EVP, Chief Strategy Officer of AbbVie Inc and owns about 98,580 shares of AbbVie Inc (ABBV) stock worth over $16 Million. Henry O Gosebruch is the President & CEO of Neumora Therapeutics Inc and owns about 524,793 shares of Neumora Therapeutics Inc (NMRA) stock worth over $5 Million. Henry O Gosebruch is also the Director of Acelyrin Inc and owns about 50,000 shares of Acelyrin Inc (SLRN) stock worth over $220,000. Besides these, Henry O Gosebruch also holds Aptinyx Inc (APTX) . Details can be seen in Henry O Gosebruch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Henry O Gosebruch has not made any transactions after 2023-09-19 and currently still holds the listed stock(s).
Transaction Summary of Henry O Gosebruch
Henry O Gosebruch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry O Gosebruch owns 4 companies in total, including Aptinyx Inc () , AbbVie Inc () , and Acelyrin Inc () among others .
Click here to see the complete history of Henry O Gosebruch’s form 4 insider trades.
Insider Ownership Summary of Henry O Gosebruch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Aptinyx Inc | 2020-01-10 | director | |
AbbVie Inc | 2022-05-16 | Chief Strategy Officer | |
Acelyrin Inc | 2023-05-09 | director | |
Neumora Therapeutics Inc | 2023-09-19 | director & President & CEO |
Henry O Gosebruch Latest Holdings Summary
Henry O Gosebruch currently owns a total of 4 stocks. Among these stocks, Henry O Gosebruch owns 98,580 shares of AbbVie Inc (ABBV) as of May 16, 2022, with a value of $16 Million and a weighting of 76.64%. Henry O Gosebruch owns 524,793 shares of Neumora Therapeutics Inc (NMRA) as of September 19, 2023, with a value of $5 Million and a weighting of 22.28%. Henry O Gosebruch also owns 50,000 shares of Acelyrin Inc (SLRN) as of May 9, 2023, with a value of $220,000 and a weighting of 1.03%. The other 1 stocks Aptinyx Inc (APTX) have a combined weighting of 0.06% among all his current holdings.
Latest Holdings of Henry O Gosebruch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABBV | AbbVie Inc | 2022-05-16 | 98,580 | 166.46 | 16,409,627 |
NMRA | Neumora Therapeutics Inc | 2023-09-19 | 524,793 | 9.09 | 4,770,368 |
SLRN | Acelyrin Inc | 2023-05-09 | 50,000 | 4.40 | 220,000 |
APTX | Aptinyx Inc | 2020-01-10 | 125,000 | 0.10 | 12,000 |
Holding Weightings of Henry O Gosebruch
Henry O Gosebruch Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 6 transactions in AbbVie Inc (ABBV) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in AbbVie Inc is the sale of 83,960 shares on May 16, 2022, which brought Henry O Gosebruch around $13 Million.
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neumora Therapeutics Inc is the acquisition of 15,000 shares on September 19, 2023, which cost Henry O Gosebruch around $189,300.
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acelyrin Inc is the acquisition of 50,000 shares on May 9, 2023, which cost Henry O Gosebruch around $900,000.
More details on Henry O Gosebruch's insider transactions can be found in the Insider Trading History of Henry O Gosebruch table.Insider Trading History of Henry O Gosebruch
- 1
Henry O Gosebruch Trading Performance
GuruFocus tracks the stock performance after each of Henry O Gosebruch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry O Gosebruch is 1.48%. GuruFocus also compares Henry O Gosebruch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry O Gosebruch within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry O Gosebruch's insider trading performs compared to the benchmark.
Performance of Henry O Gosebruch
Average Return
21.28%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -10.12 | 1.48 | -0.29 | 21.28 | 1.62 | -19.31 |
Relative Return to S&P 500(%) | -10.1 | 0.72 | -7.37 | 12.38 | -18.95 | -29.3 |
Henry O Gosebruch Ownership Network
Ownership Network List of Henry O Gosebruch
Ownership Network Relation of Henry O Gosebruch
Henry O Gosebruch Owned Company Details
What does Aptinyx Inc do?
Who are the key executives at Aptinyx Inc?
Henry O Gosebruch is the director of Aptinyx Inc. Other key executives at Aptinyx Inc include director & CEO and President Norbert G Riedel , CFO and CBO Ashish Khanna , and 10 percent owner Bain Capital Life Sciences Investors, Llc .
Aptinyx Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptinyx Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptinyx Inc Insider Transactions
Henry O Gosebruch Mailing Address
Above is the net worth, insider trading, and ownership report for Henry O Gosebruch. You might contact Henry O Gosebruch via mailing address: 1 N. Waukegan Road, North Chicago Il 60064-6092.